Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > just thinking out loud...isnt it strange that they drop this

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Aug 17, 2021 4:50pm

71 Views

Post# 33718609

RE:RE:just thinking out loud...isnt it strange that they drop this

Fro those who missed beyond all the pumping....

stockbuphoon wrote: Maybe you should think about why they said 2 weeks ago that small molecule was their future and then they shut doen their top 2 trials which were still years away from FDA approval if everything went well. What do they have now? Think about that? Preclinical?

Why did they schedule AGM on May 4th before PDUFA date?

They are shutting this down. Next week. Thomson is trying to pretend its worth nothing and he will sell it to Boehringher privately in a year or 2 - no retailer will get a penny. It sucks.

realstocky wrote: just before an expected FDA ok on riplazym, probably next week...... maybe u should think about it too;)